Adage Capital Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-150,000
Closed -$48.8M 964
2024
Q1
$48.8M Buy
+150,000
New +$36.8M 0.09% 230
2020
Q2
Sell
-225,000
Closed -$7.47M 808
2020
Q1
$7.47M Buy
225,000
+150,000
+200% +$5.96M 0.02% 519
2019
Q4
$3.29M Buy
+75,000
New +$2.77M 0.01% 640
2019
Q2
Sell
-200,000
Closed -$6.69M 767
2019
Q1
$6.69M Buy
+200,000
New +$6.64M 0.02% 579

Other funds holding SWAV

Adage Capital Partners's SWAV Position: Q2 2024 in Review

Adage Capital Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 150,000 shares — an estimated $48.8M sold.

Adage Capital Partners first reported a position in SWAV in Q1 2019 and held it in 4 quarters. The position peaked at $48.8M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Adage Capital Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Adage Capital Partners sold 150,000 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $48.8M.
  • Adage Capital Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • Adage Capital Partners's Shockwave Medical, Inc. Common Stock position peaked at $48.8M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Adage Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.